6533b85cfe1ef96bd12bd494
RESEARCH PRODUCT
Bio-silica and bio-polyphosphate: applications in biomedicine (bone formation)
Heinz C. SchröderHiroshi UshijimaXiaohong WangMatthias WiensWerner E. G. M�llersubject
musculoskeletal diseasesSiliconAnabolismBiomedical EngineeringOsteoclastsBioengineering02 engineering and technologyBone morphogenetic protein 2Phosphates03 medical and health sciencesMediatorOsteogenesisAnimalsHumansProgenitor cell030304 developmental biology0303 health sciencesOsteoblastsbiologyCatabolismChemistry021001 nanoscience & nanotechnologySilicon DioxideIn vitro3. Good healthCell biologyPoriferaRANKLImmunologybiology.proteinOsteoporosisBone Diseases0210 nano-technologyFunction (biology)Biotechnologydescription
Bio-silica represents the main mineral component of the sponge skeletal elements (siliceous spicules), while bio-polyphosphate (bio-polyP), a multifunctional polymer existing in microorganisms and animals acts, among others, as reinforcement for pores in cell membranes. These natural inorganic bio-polymers, which can be readily prepared, either by recombinant enzymes (bio-silica and bio-polyP) or chemically (polyP), are promising materials/substances for the amelioration and/or treatment of human bone diseases and dysfunctions. It has been demonstrated that bio-silica causes in vitro a differential effect on the expression of the genes OPG and RANKL, encoding two mediators that control the tuned interaction of the anabolic (osteoblasts) and catabolic (osteoclasts) pathways in human bone cells. Since bio-silica and bio-polyP also induce the expression of the key mediator BMP2 which directs the differentiation of bone-forming progenitor cells to mature osteoblasts and in parallel inhibits the function of osteoclasts, they are promising candidates for treatment of osteoporosis.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2012-02-25 | Curr. Opin. Biotechnol. |